Compare LZB & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LZB | VIR |
|---|---|---|
| Founded | 1927 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 1994 | 2019 |
| Metric | LZB | VIR |
|---|---|---|
| Price | $32.73 | $11.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $39.00 | $19.43 |
| AVG Volume (30 Days) | 588.6K | ★ 1.5M |
| Earning Date | 06-16-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.75% | N/A |
| EPS Growth | 5.11 | ★ 17.49 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,349,433,000.00 | $68,556,000.00 |
| Revenue This Year | $1.89 | $270.22 |
| Revenue Next Year | $2.09 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $29.03 | $4.75 |
| 52 Week High | $44.90 | $11.66 |
| Indicator | LZB | VIR |
|---|---|---|
| Relative Strength Index (RSI) | 28.57 | 73.93 |
| Support Level | $31.76 | $8.43 |
| Resistance Level | $39.96 | $11.66 |
| Average True Range (ATR) | 1.22 | 0.51 |
| MACD | -0.96 | 0.25 |
| Stochastic Oscillator | 9.01 | 93.86 |
La-Z-Boy Inc is a world'wide producer of reclining chairs and one of the manufacturers/distributors of residential furniture in the United States. It manufacture, market, import, export, distribute and retail upholstery furniture products. In addition, it import, distribute and retail accessories and casegoods (wood) furniture products. Its reportable operating segments include the Retail segment and the Wholesale segment. Its Retail segment mainly sells upholstered furniture. Wholesale segment manufactures and imports upholstered and casegoods (wood) furniture and sells directly. The company generates majority of revenue from Wholesale segment which manufactures and imports upholstered furniture, such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, etc.
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.